2022
DOI: 10.3389/fgene.2022.981222
|View full text |Cite
|
Sign up to set email alerts
|

Development of a prognostic prediction model based on a combined multi-omics analysis of head and neck squamous cell carcinoma cell pyroptosis-related genes

Abstract: This study aimed to understand the prognosis of patients with head and neck squamous cell carcinoma (HNSCC) and to develop and validate a prognostic model for HNSCC based on pyroptosis-associated genes (PAGs) in nasopharyngeal carcinoma. The Cancer Genome Atlas database was used to identify differentially expressed PAGs. These genes were analyzed using the Kyoto Encyclopedia of Genes and Genomes functional annotation analyses and Gene Ontology analyses. The NLR family pyrin domain containing 1 (NLRP1) gene, ch… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 73 publications
0
3
0
Order By: Relevance
“…Oncostatin M (OSM) can promote the potential of breast cancer metastasis (Covert et al 2019 ). Charged multivesicular body protein 7 (CHMP7) has been shown to be a risk gene for squamous cell carcinoma of the head and neck (Chen et al 2022 ). Fragile X mental retardation 1 (FMR1) has been identified as a new immune-related prognostic biomarker for renal clear cell carcinoma (Wu et al 2022 ).…”
Section: Discussionmentioning
confidence: 99%
“…Oncostatin M (OSM) can promote the potential of breast cancer metastasis (Covert et al 2019 ). Charged multivesicular body protein 7 (CHMP7) has been shown to be a risk gene for squamous cell carcinoma of the head and neck (Chen et al 2022 ). Fragile X mental retardation 1 (FMR1) has been identified as a new immune-related prognostic biomarker for renal clear cell carcinoma (Wu et al 2022 ).…”
Section: Discussionmentioning
confidence: 99%
“…Predictive models can also assist physicians in implementing precision medicine, thereby formulating more personalized and efficacious treatment plans ( Pencina & Peterson, 2016 ; Obermeyer & Emanuel, 2016 ; Kang et al, 2020 ; Wu et al, 2021 ; Lin et al, 2022 ; Chen et al, 2022a ). These models can enhance research efficiency, accelerate the development of novel pharmaceuticals, and optimize therapeutic strategies, ultimately making significant contributions to the improvement of human health.…”
Section: Introductionmentioning
confidence: 99%
“…Cancer immunotherapy, mainly employing immune checkpoint inhibitors and immune cell recombination therapy, has substantially improved patient survival outcomes, emphasizing the crucial significance of immunological and related biomarkers ( Sharma & Allison, 2015 ; Hargadon, Johnson & Williams, 2018 ; Xu et al, 2021 ; Sun et al, 2022b ; Mei, Li & Kang, 2022 ; Chen et al, 2022a ; Luo et al, 2022 ). Nevertheless, immunotherapy’s efficacy remains relatively low in cancer patients.…”
Section: Introductionmentioning
confidence: 99%